© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

CLOs

Latest news

Latest news

Market anticipates another record year for new issuance, even as equity returns remain weak
Rating upgrades to CLO tranches by Moody's and Fitch could let managers increase leverage in deals
Manager takes advantage of tight spreads available for refinancings to cut triple-A pricing by 14bp
More articles

More articles

  • Natixis CIB Americas is spying growth across its global structured credit and conduits platform while bank counterparts in Europe are struggling with exposure to the sovereign credit crisis, according to Yann Gindre, ceo.
  • Lehman Brothers Holdings has entered into an agreement under which WCAS Fraser Investment would manage $5.3 billion of the fallen firm’s commercial-loan portfolio with the goal of turning it into cash quickly.
  • Issuance of U.S. collateralized loan obligations will continue at a robust pace through the end of 2011 “with little broader market interference,” according to Fitch Ratings.
  • The U.K. Supreme Court today upheld the flip clause in Lehman Brothers’ synthetic collateralized debt obligations, which made Lehman subordinate to noteholders in the waterfall of payments when the firm filed for bankruptcy in 2008.
  • Distributions to equity tranches in European collateralized loan obligations continue to lag behind flow to U.S. CLOs, according to Morgan Stanley analysts in a client call Tuesday.
  • Varden Pacific, a new hedge fund launched in San Francisco in April, has bought USD4 million of a tranche of a legacy synthetic collateralized debt obligation created in 2005 maturing in 2013.
  • Kevin Alexander has been tapped to run the global structured credit and conduit business at Natixis CIB Americas
  • Guggenheim Securities has arranged a collateralized loan obligation-like bond backed largely by loans to young medical, biotech and pharmaceutical companies.
  • Lloyds Banking Group has priced its £1.26 billion ($2.05 billion) Sandown Gold 2011 small-to-medium enterprise collateralized loan obligation, a positive sign in a gruelling month for European securitization.